You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Investigational Drug Information for Arbaclofen


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Arbaclofen?

Arbaclofen is an investigational drug.

There have been 29 clinical trials for Arbaclofen. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Autism Spectrum Disorder, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are Seaside Therapeutics, Inc., Indivior Inc., and Osmotica Pharmaceutical US LLC.

Recent Clinical Trials for Arbaclofen
TitleSponsorPhase
A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple SclerosisRVL Pharmaceuticals, Inc.Phase 3
Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 DeletionClinical Research Associates, LLCPhase 2
Arbaclofen in Children and Adolescents With ASDHospital General Universitario Gregorio MarañonPhase 2

See all Arbaclofen clinical trials

Clinical Trial Summary for Arbaclofen

Top disease conditions for Arbaclofen
Top clinical trial sponsors for Arbaclofen

See all Arbaclofen clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.